Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHAA4549A in Influenza Challenge Model
NCT01980966Phase 2Completed
- Sponsor
- Genentech
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of vedolizumab in Influenza A (IAV), sponsored by Genentech. Started Nov 2013; status: completed.
02
Drugs
vedolizumab
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT01980966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980966.